MIM
MetLife Investment Management Portfolio holdings
AUM
$17B
1-Year Return
25.61%
This Quarter Return
+0.51%
1 Year Return
+25.61%
3 Year Return
+108.53%
5 Year Return
+194.13%
10 Year Return
–
AUM
$11.2B
AUM Growth
-$244M
(-2.1%)
Cap. Flow
-$177M
Cap. Flow
% of AUM
-1.59%
Top 10 Holdings %
Top 10 Hldgs %
22.89%
Holding
2,613
New
177
Increased
266
Reduced
1,243
Closed
46
Top Buys
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
$38.6M |
| 2 |
SPDR S&P MidCap 400 ETF Trust
MDY
|
$33.6M |
| 3 |
Moderna
MRNA
|
$30.5M |
| 4 |
iShares MSCI EAFE ETF
EFA
|
$17.8M |
| 5 |
Match Group
MTCH
|
$9.81M |
Top Sells
| 1 |
Energy Transfer Partners
ET
|
$37.2M |
| 2 |
Microsoft
MSFT
|
$13.8M |
| 3 |
Apple
AAPL
|
$12.7M |
| 4 |
ALXN
Alexion Pharmaceuticals Inc
ALXN
|
$9.28M |
| 5 |
MXIM
Maxim Integrated Products
MXIM
|
$6.56M |
Sector Composition
| 1 | Technology | 21.21% |
| 2 | Financials | 13.16% |
| 3 | Healthcare | 12.66% |
| 4 | Consumer Discretionary | 11.48% |
| 5 | Industrials | 8.86% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
TECX
2501
Tectonic Therapeutic, Inc. Common Stock
TECX
$314M
| $81.8K | ﹤0.01% |
1,221
+1,096
| +877% | +$73.4K |
|
2502
Civista Bancshares
CIVB
$406M
| $80.5K | ﹤0.01% |
3,464
-3,645
| -51% | -$84.7K |
|
2503
Allient
ALNT
$772M
| $79.1K | ﹤0.01% |
2,529
-2,652
| -51% | -$83K |
|
2504
Entravision Communication
EVC
$226M
| $78.3K | ﹤0.01% |
11,027
-11,953
| -52% | -$84.9K |
|
2505
XBiotech
XBIT
$89M
| $76.3K | ﹤0.01% |
+5,892
| New | +$76.3K |
|
|
AKTS
2506
DELISTED
AKOUSTIS TECHNOLOGIES, INC.
AKTS
| $75.6K | ﹤0.01% |
7,791
-8,187
| -51% | -$79.4K |
|
|
KBAL
2507
DELISTED
Kimball International
KBAL
| $75.2K | ﹤0.01% |
6,716
-6,989
| -51% | -$78.3K |
|
2508
Barnes & Noble Education
BNED
$291M
| $74.3K | ﹤0.01% |
74
-75
| -50% | -$75.4K |
|
2509
Marcus Corp
MCS
$483M
| $72.6K | ﹤0.01% |
4,158
-5,085
| -55% | -$88.7K |
|
2510
Motorcar Parts of America
MPAA
$281M
| $71.1K | ﹤0.01% |
3,648
-4,352
| -54% | -$84.9K |
|
2511
Esperion Therapeutics
ESPR
$540M
| $71K | ﹤0.01% |
5,894
-6,792
| -54% | -$81.8K |
|
2512
Kopin
KOPN
$345M
| $70K | ﹤0.01% |
13,644
-14,585
| -52% | -$74.8K |
|
2513
Athira Pharma
ATHA
$15.4M
| $69.2K | ﹤0.01% |
7,380
-7,972
| -52% | -$74.8K |
|
2514
Cartesian Therapeutics
RNAC
$277M
| $68.5K | ﹤0.01% |
549
-656
| -54% | -$81.9K |
|
2515
Atossa Therapeutics
ATOS
$102M
| $64.9K | ﹤0.01% |
19,919
-24,081
| -55% | -$78.5K |
|
2516
Carter Bankshares
CARE
$442M
| $61.3K | ﹤0.01% |
+4,313
| New | +$61.3K |
|
2517
Aveanna Healthcare
AVAH
$1.72B
| $61.3K | ﹤0.01% |
7,647
-9,406
| -55% | -$75.4K |
|
2518
TETRA Technologies
TTI
$625M
| $58.7K | ﹤0.01% |
18,820
-27,463
| -59% | -$85.7K |
|
2519
Blue Bird Corp
BLBD
$1.87B
| $58K | ﹤0.01% |
2,782
-4,083
| -59% | -$85.2K |
|
2520
Titan International
TWI
$562M
| $57K | ﹤0.01% |
7,965
-11,326
| -59% | -$81.1K |
|
2521
InnovAge Holding
INNV
$512M
| $56K | ﹤0.01% |
8,476
| – | – |
|
2522
Karyopharm Therapeutics
KPTI
$57.2M
| $55.6K | ﹤0.01% |
637
-944
| -60% | -$82.4K |
|
|
SIEN
2523
DELISTED
Sientra, Inc.
SIEN
| $55K | ﹤0.01% |
959
-1,366
| -59% | -$78.3K |
|
2524
Universal Insurance Holdings
UVE
$697M
| $54.8K | ﹤0.01% |
4,204
-6,375
| -60% | -$83.1K |
|
2525
Dorian LPG
LPG
$1.33B
| $54.6K | ﹤0.01% |
4,400
-7,018
| -61% | -$87.1K |
|